<DOC>
	<DOC>NCT00206063</DOC>
	<brief_summary>The purpose of this study is to evaluate tolerability of long-term treatment with ximelagatran compared to standard treatment with warfarin.</brief_summary>
	<brief_title>Long Term Open Follow-up With H376/95 vs. Warfarin</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Ximelagatran</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Signed informed consent. Completion of the study SHTPA0002, history of chronic atrial fibrillation (i.e. rapidly beating heart), at least one risk factor for stroke (e.g. high blood pressure, age over 65, previous stroke or similar attack, diabetes or coronary heart disease) Conditions associated with increased risk of bleeding, renal impairment, known active liver disease or liver insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>